Structural Heart Devices Market Size, Share, Growth, and Industry Analysis, By type (Structural Heart Repair Devices and Replacement Devices), By Application (Adults and Pediatric), and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

STRUCTURAL HEART DEVICES MARKET OVERVIEW

The global Structural Heart Devices Market Size was USD 11.19 billion in 2025 and is projected to touch USD 24.77 billion by 2034, exhibiting a CAGR of 10.44% during the forecast period.

The United States Structural Heart Devices market size is projected at USD 3929.19 million in 2025, the Europe Structural Heart Devices market size is projected at USD 3034.77 million in 2025, and the China Structural Heart Devices market size is projected at USD 2950.81 million in 2025.

The creation, production, and distribution of medical devices for the replacement or repair of diseased or damaged heart components, namely heart valves and septa, are all included in the structural heart devices market. Valvular heart disease (such as aortic stenosis and mitral regurgitation) and congenital heart defects are among the conditions that these devices treat. This factor has augmented Structural Heart Devices Market growth.

The anticipated rate of growth for this particular product service is due to quality level of assurance. Prosperity has been observed for this particular product market with amusing numbers. This shows how widely these devices can be used to treat structural heart defects. For patients with congenital heart disease (CHD) and acquired heart disease (ACD), structural heart disease (SHD) treatment encompasses a broad range of percutaneous procedures related to structural and functional abnormalities of the heart valves, proximal great arteries, and cardiac chambers.

COVID-19 IMPACT

Market Growth Obstructed by Pandemic due to Lockdown

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

This has affected the overall supply and demand chains of the particular market. As a result of the government's lockdown and other steps to stop the coronavirus from spreading, all supply activities were postponed, which decreased the amount of product related to services. Therefore, a small influence from COVID-19 is anticipated on the Structural Heart Devices Market share.

LATEST TRENDS

Illness Affecting Infants to Drive Market Growth

This specific trend has influenced the market growth so much that the revenue and share numbers of this particular product are touching the skies and soaring over. A lot of specifications have been made to this particular product which has benefited the market growth. A latest trend has been witnessed to proliferate market growth. The increase in the number of patients with structural heart problems is probably going to drive the market. These illnesses commonly affect infants since they are typically congenital. People with these conditions are gravitating toward tissue-enhanced aortic valves because they aid in the structural replacement and repair of the heart. The way structural heart devices work has improved with the development of technology. People's life expectancy and level of living have increased as a result of the better therapies. Structural heart surgeries are preferred over more invasive procedures like open heart surgeries because they are less invasive.

•   
•   
  

  Request a Free sample to learn more about this report

    

STRUCTURAL HEART DEVICES MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Structural Heart Repair Devices and Replacement Devices.

• Structural Heart Repair Devices: The market for structural heart devices as a whole includes the category of structural heart repair devices. These devices are especially made to address structural defects or abnormalities of the heart, either by closing aberrant holes in the heart or by replacing or repairing damaged cardiac components like valves or septa. Not much helpful but it has been observed that this segment has contributed to the overall shares development system for this particular product market services.

• Replacement Devices: Replacement devices are medical devices used to replace a diseased or damaged heart valve, either surgically or by a minimally invasive process, in the context of the structural heart devices market. The market for structural cardiac interventions, which also includes repair devices, includes these devices as a significant category.

By Application

Based on application, the global market can be categorized into Adults and Pediatric.

• Adults: This particular segment was recorded to be the leading segment with holding the most amount of shares. The market for medical devices used to treat adult patients with structural heart defects is known as the Adults in Structural Heart Devices Market. These devices are intended to close holes in the heart, fix structural abnormalities, or replace or repair damaged heart valves. Not to mention but this particular segment has actually risen the share and revenue numbers for the market.

• Pediatric: The development and marketing of medical devices for the treatment of congenital heart disorders and other heart defects in children is the main focus of the pediatric structural heart devices market. These include transcatheter cardiac valves, devices for sealing septal defects (ASD, VSD, and PDA), and other associated technologies such as stents, guidewires, and catheters.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Coronary Artery Diseases and Strategic Investments To Boost the Market

These factors are anticipated to drive the market growth in the present times and also during the forecast period. This particular product market has touched new levels of lucrative revenue numbers and has also recorded to be the boon for this particular product market growth. This is the major factor attributing the growth of this particular market and has resulted in the hike of revenue numbers so much so that they are touching the skies. Clients benefit from it. The prevalence of cardiovascular illness has increased due in large part to the aging of the world's population, which directly affects the need for structural cardiac treatments. The need for minimally invasive treatments that enhance patient outcomes and lower healthcare costs is driving the growing prevalence of age-related disorders like heart failure and valve disease, which in turn is driving the need for structural cardiac devices. An important factor driving the demand for structural cardiac devices is the rising incidence of cardiovascular conditions like heart failure, arrhythmias, and coronary artery disease. The prevalence of cardiovascular diseases is rising as the world's population ages and lifestyle choices like smoking, poor food, and inactivity continue to increase, necessitating the development of sophisticated cardiac devices and therapies. The market players' strategic actions, the growing burden of depression, and increased R&D efforts are all anticipated to contribute to the segment's growth throughout the forecast period. This particular growth factor has also been creating opportunities for the success of this market product market path.

Developing Cardiology and New Developments to Expand the Market

This is the second major factor attributing the growth of this particular market. This factor is majorly involved in taking the revenue numbers above the skies and soaring greater heights and also the sales and demands have been proliferation and increased its value to greater extent. Devices like heart valves, stents, and pacemakers are needed to restore normal heart function since conditions like coronary artery disease and heart failure, in particular, are leading causes of morbidity and mortality globally. The need for state-of-the-art technology that promotes improved outcomes in heart disease therapies is further highlighted by ongoing developments in cardiology, such as the development of new, more durable structural cardiac devices and minimally invasive procedures. The need for structural heart devices, which guarantee better surgical results and lower the risks connected with heart procedures, is only increasing as more people receive cardiovascular disease diagnoses and seek treatment. This particular factor has been proved to be a boon for this particular product market.

Restraining Factor

High Cost of Raw Materials to Impede Market Growth

The price volatility of raw materials is one of the main restraints, as it can have a substantial effect on market participants' profitability and production costs. These particular solutions have been very helpful yet extremely costly as well. This particular factor is anticipated to restrain the market growth and drastically reduce the sales and demands of this particular product market. One major obstacle to the market is the expensive cost of structural heart implants, which restricts their use, especially in developing nations and smaller medical facilities with tighter budgets. Considering the continuous need for follow-up treatments and lifelong monitoring, devices like heart pumps and transcatheter valves can be quite costly, placing a significant financial burden on individuals and healthcare systems. The market is hampered by high production costs. Threats and limiting factors are not absent from the market. Manufacturers' profitability and the cost of their products can both be impacted by changes in the price of essential raw materials. The market is also vulnerable to some risks that could impede its expansion.

Technological Advancements To Create Opportunity for the Product in the Market

Opportunity

These businesses must differentiate themselves in the market by offering innovative goods and services if they want to compete. The incorporation of enhanced imaging and artificial intelligence (AI) into minimally invasive surgical techniques is one of the major potential in the global market for structural cardiac devices.

Patients undergoing cardiac valve replacement or repair may benefit from more individualized treatments, fewer problems, and better long-term results thanks to AI and real-time imaging, which can improve procedural accuracy. This particular opportunity has been attributed to the market growth immensely. This opportunity has been creating a path for easy success for this particular market segment if seized on time.

High Initial Investment Could Be a Potential Challenge for Consumers

Challenge

But the high cost of research and development skills is expected to be a barrier to market expansion. This particular factor has been drastically challenging for the market growth and has become another major restraining factor.

This particular factor has been proved to be a bane for this industry which has, in terms, affected the shares and revenue systems for this particular market drastically on a global level.

•   
•   
  Request a Free sample to learn more about this report

    

STRUCTURAL HEART DEVICES MARKET REGIONAL INSIGHTS

• North America

The North American region has augmented a lot in the past few years in this particular product market. The United States Structural Heart Devices Market has anticipated to augment immensely over the forecast period. This particular region is actually growing a lot and is anticipated to augment more over the years. The need for isolator gloves has increased as a result of this regulatory environment.

• Europe

The European market for this particular market has been accounted for attributing the overall global shares for this particular product service market. The second-largest revenue share was held by Europe, which is expected to increase throughout the forecast period. Europe is expected to have a substantial market. Europe is probably going to grow. Europe is not far behind North America.

• Asia

The Asia-Pacific area is anticipated to grow. This particular region has experienced immense proliferation in the market shares and has attributed to the global market revenue. The region with the fastest growth rate throughout the projected period is anticipated to be Asia Pacific. This particular region is actually growing a lot and is anticipated to augment more over the years. Asia-Pacific is anticipated to expand at the fastest rate during the projection period due to a rise in the demand for cutting-edge technologies.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

List Of Top Companies 

• Boston Scientific Corporation (U.S.)
• Edwards Lifesciences Corp. (U.S.)
• Medtronic, Plc (Ireland)
• Livanova Plc (U.K.)
• Abbott Laboratories (U.S.)

KEY INDUSTRY DEVELOPMENT

May 2025: This particular company has attributed the market growth in terms of revenue and shares system. In order to provide a surgical option for severe mitral annular calcification, Abbott's Tendyne transcatheter mitral valve replacement system was approved by the FDA.

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive.